Metlife Inc. buy piccolo90
Summary
This prediction ended on 09.11.16 with a price of €44.95. The BUY prediction by piccolo90 finished with a performance of 18.60%. piccolo90 has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Metlife Inc. | -1.899% | -1.899% | -1.632% | 20.578% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % | 50,71 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % | 102,82 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % | 64,80 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % | 70,25 % |
Comments by piccolo90 for this prediction
In the thread Metlife Inc. diskutieren
piccolo90 stimmt der Outperform-Einschätzung der institutionellen Analysten zu
piccolo90 stimmt am 14.07.2016 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 49.29$ zu.


